Stock Split History
ETFs Holding EW »    EW Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Edwards Lifesciences is engaged in medical treatments for structural heart disease and critical care monitoring. Co. manufactures heart valve systems and repairs products used to replace or repair a patient's diseased or defective heart valve. Co.'s technologies is focused on the less invasive repair or replacement of the mitral and tricuspid valves of the heart. Co. is also engaged in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. Co.'s products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Surgical Structural Heart, Critical Care, and Transcatheter Mitral and Tricuspid Therapies. According to our Edwards Lifesciences stock split history records, Edwards Lifesciences has had 3 splits.
Edwards Lifesciences stock split history picture
Edwards Lifesciences (EW) has 3 splits in our Edwards Lifesciences stock split history database. The first split for EW took place on May 27, 2010. EW's second split took place on May 28, 2010. This was a 2 for 1 split, meaning for each share of EW owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. EW's third split took place on December 14, 2015. This was a 2 for 1 split, meaning for each share of EW owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.

When a company such as Edwards Lifesciences splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the Edwards Lifesciences stock split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Edwards Lifesciences shares, starting with a $10,000 purchase of EW, presented on a split-history-adjusted basis factoring in the complete Edwards Lifesciences stock split history. Edwards Lifesciences split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/29/2009
End date: 06/26/2019
Start price/share: $16.79
End price/share: $187.05
Dividends collected/share: $0.00
Total return: 1,014.06%
Average Annual Total Return: 27.27%
Starting investment: $10,000.00
Ending investment: $111,422.66
Years: 10.00
Date Ratio
05/27/20101 for 1
05/28/20102 for 1
12/14/20152 for 1
EW is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

EXAC Split History
FCSC Split History
FRX Split History
GALE Split History
GALT Split History
GBSN Split History
GENE Split History
GERN Split History
GILD Split History
GNCA Split History

Also explore: EW shares outstanding history

Xenetic Biosciences, Inc. (XBIO)
Yuma Energy, Inc. (YUMA)
Avinger, Inc. (AVGR)
Sonoma Pharmaceuticals, Inc. (SOMA)
Hudson Global, Inc. (HSON)
Jaguar Health, Inc. (JAGX)
Cesca Therapeutics Inc. (KOOL)
Northern Technologies International Corporation (NTIC)
Digirad Corporation (DRAD)
Hemispherx Biopharma, Inc. (HEB)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Edwards Lifesciences
Edwards Lifesciences Insider Buying

Edwards Lifesciences Stock Split History | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.